Cilazapril

This classification denotes an ace inhibitor with the molecular formula C22H31N3O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 8Q9454114Q, chemically known as 6h-pyridazino(1,2-a)(1,2)diazepine-1-carboxylic acid, octahydro-9-((1-(ethoxycarbonyl)-3-phenylpropyl)amino)-10-oxo-, hydrate, (1s-(1-alpha,9-alpha(r*)))- but generally known as cilazapril, which bears US NIH Compound Identifier 56329. European Medicines Agency schedules Cilazapril in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06265MIG. The term CILAZAPRIL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 39, No. 5, 1985, List 25). World Health Organization schedules cilazapril in its Anatomical Therapeutic Chemical (ATC) Classification. CILAZAPRIL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule cilazapril under HS 29339940 and SITC 51577. SMILES: O=C1N2N(CCCC2C(=O)O)CCCC1NC(CCc1ccccc1)C(=O)OCC.O.